<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08009</article-id><article-id pub-id-type="doi">10.7554/eLife.08009</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genes and Chromosomes</subject></subj-group></article-categories><title-group><article-title>LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-33084"><name><surname>Ito</surname><given-names>Ayaka</given-names></name><aff><institution content-type="dept">Department of Pathology and Laboratory Medicine</institution>, <institution>Howard Hughes Medical Institute, University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33085"><name><surname>Hong</surname><given-names>Cynthia</given-names></name><aff><institution content-type="dept">Department of Pathology and Laboratory Medicine</institution>, <institution>Howard Hughes Medical Institute, University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27820"><name><surname>Rong</surname><given-names>Xin</given-names></name><aff><institution content-type="dept">Department of Pathology and Laboratory Medicine</institution>, <institution>Howard Hughes Medical Institute, University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33086"><name><surname>Zhu</surname><given-names>Xuewei</given-names></name><aff><institution content-type="dept">Department of Internal Medicine-Section on Molecular Medicine</institution>, <institution>Wake Forest School of Medicine</institution>, <addr-line><named-content content-type="city">Winston-Salem</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-8652"><name><surname>Tarling</surname><given-names>Elizabeth J</given-names></name><aff><institution content-type="dept">Department of Medicine</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27823"><name><surname>Hedde</surname><given-names>Per Niklas</given-names></name><aff><institution content-type="dept">Laboratory of Fluorescence Dynamics, Biomedical Engineering Department, Center for Complex Biological Systems</institution>, <institution>University of California, Irvine</institution>, <addr-line><named-content content-type="city">Irvine</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16208"><name><surname>Gratton</surname><given-names>Enrico</given-names></name><aff><institution content-type="dept">Laboratory of Fluorescence Dynamics, Biomedical Engineering Department, Center for Complex Biological Systems</institution>, <institution>University of California, Irvine</institution>, <addr-line><named-content content-type="city">Irvine</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33087"><name><surname>Parks</surname><given-names>John</given-names></name><aff><institution content-type="dept">Department of Internal Medicine-Section on Molecular Medicine</institution>, <institution>Wake Forest School of Medicine</institution>, <addr-line><named-content content-type="city">Winston-Salem</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1193"><name><surname>Tontonoz</surname><given-names>Peter</given-names></name><aff><institution>Howard Hughes Medical Institute, University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country><email>ptontonoz@mednet.ucla.edu</email></aff><xref ref-type="fn" rid="conf2"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1142"><name><surname>Medzhitov</surname><given-names>Ruslan</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, Yale University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>14</day><month>07</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e08009</elocation-id><supplementary-material><ext-link xlink:href="elife-08009-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>17</day><month>04</month><year>2015</year></date><date date-type="accepted"><day>13</day><month>07</month><year>2015</year></date></history><permissions><copyright-statement>© 2015, Ito et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Ito et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>The liver X receptors (LXRs) are transcriptional regulators of lipid homeostasis that also have potent anti-inflammatory effects. The molecular basis for their anti-inflammatory effects is incompletely understood, but has been proposed to involve the indirect tethering of LXRs to inflammatory gene promoters. Here we demonstrate that the ability of LXRs to repress inflammatory gene expression in cells and mice derives primarily from their ability to regulate lipid metabolism through transcriptional activation and can occur in the absence of SUMOylation. Moreover, we identify the putative lipid transporter Abca1 as a critical mediator of LXR's anti-inflammatory effects. Activation of LXR inhibits signaling from TLRs 2, 4 and 9 to their downstream NF-κB and MAPK effectors through Abca1-dependent changes in membrane lipid organization that disrupt the recruitment of MyD88 and TRAF6. These data suggest that a common mechanism-direct transcriptional activation-underlies the dual biological functions of LXRs in metabolism and inflammation.</p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author keywords</title><kwd>lipid metabolism</kwd><kwd>LXR</kwd><kwd>nuclear receptor</kwd><kwd>Toll-like receptor</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Peter Tontonoz, Reviewing editor, eLife.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#99-131 and 2003-166) of the University of California, Los Angeles.</p></fn></fn-group></back></article>